• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型基于三唑的杂合物作为亲神经药物。

New triazole-based hybrids as neurotropic agents.

作者信息

Sirakanyan Samvel N, Spinelli Domenico, Geronikaki Athina, Hakobyan Elmira K, Petrou Anti, Kartsev Victor G, Yegoryan Hasmik A, Paronikyan Ervand G, Zuppiroli Luca, Jughetsyan Hasmik V, Paronikyan Ruzanna G, Arakelyan Tatevik A, Hovakimyan Anush A

机构信息

Scientific Technological Center of Organic and Pharmaceutical Chemistry of National Academy of Science of Republic of Armenia, Institute of Fine Organic Chemistry of A.L. Mnjoyan 0014 Armenia

Dipartimento di Chimica G. Ciamician, Alma Mater Studiorum-Università di Bologna Via F. Selmi 2 Bologna 40126 Italy

出版信息

RSC Adv. 2024 Oct 18;14(45):32922-32943. doi: 10.1039/d4ra06121g. eCollection 2024 Oct 17.

DOI:10.1039/d4ra06121g
PMID:39429923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11487511/
Abstract

Herein, we describe the synthesis of new hybrids linked to 1,2,3- and 1,2,4-triazole units. Hybrids connected to a 1,2,3-triazole ring were synthesized using the well-known click reaction. The synthesis of the 1,2,4-triazole-based hybrids was carried out using 2-[(4-cyano-1-methyl(2-furyl)-5,6,7,8-tetrahydroisoquinolin-3-yl)oxy]acetohydrazides as starting compounds. The compounds were evaluated for their anticonvulsive activity antagonism towards pentylenetetrazole (PTZ) - and thiosemicarbazide (TSC)-induced convulsion and maximal electroshock-induced seizure (MES). Furthermore, the most active compounds were studied for their locomotory and anxiolytic activity the "open field" and elevated plus maze (EPM) assays. Finally, their antidepressant activity was studied the "forced swim" method. All the hybrids displayed pentylenetetrazole antagonism, ranging from 40% to 80%, while in the TSC model, the most active compounds increased latency of thiosemicarbazide seizures to 1.9-4.65 times compared to that of the control. Some of the tested compounds exhibited a pronounced anxiolytic and antidepressant effect. Docking study demonstrated complete agreement with experimental pharmacological data. It was revealed that the most active compounds have a pyrano[3,4-]pyridine ring in their structure.

摘要

在此,我们描述了与1,2,3 - 和1,2,4 - 三唑单元相连的新型杂化物的合成。与1,2,3 - 三唑环相连的杂化物通过著名的点击反应合成。以2 - [(4 - 氰基 - 1 - 甲基(2 - 呋喃基)-5,6,7,8 - 四氢异喹啉 - 3 - 基)氧基]乙酰肼为起始化合物进行了基于1,2,4 - 三唑的杂化物的合成。对这些化合物进行了抗惊厥活性评估,包括对戊四氮(PTZ) - 和氨基硫脲(TSC)诱导的惊厥以及最大电休克诱导的癫痫发作(MES)的拮抗作用。此外,对活性最高的化合物进行了运动和抗焦虑活性研究,采用“旷场”和高架十字迷宫(EPM)试验。最后,采用“强迫游泳”方法研究了它们的抗抑郁活性。所有杂化物均表现出40%至80%的戊四氮拮抗作用,而在TSC模型中,活性最高的化合物使氨基硫脲癫痫发作的潜伏期比对照组延长至1.9 - 4.65倍。一些受试化合物表现出明显的抗焦虑和抗抑郁作用。对接研究表明与实验药理学数据完全一致。结果表明,活性最高的化合物在其结构中含有一个吡喃并[3,4 - ]吡啶环。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/9881c022a578/d4ra06121g-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/33f22f4e676a/d4ra06121g-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/cc696b336cd6/d4ra06121g-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/7025f395a82d/d4ra06121g-s2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/0381248abba6/d4ra06121g-s3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/44a919789f77/d4ra06121g-s4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/39f4d4a9134d/d4ra06121g-s5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/ab7bc088cb29/d4ra06121g-c1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/1ccd61560319/d4ra06121g-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/1e75ed21b69f/d4ra06121g-c2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/a92a3b61e0bf/d4ra06121g-c3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/5051a4848ebf/d4ra06121g-c4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/ac6d838cabaa/d4ra06121g-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/294b16497184/d4ra06121g-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/ada5f1ef4713/d4ra06121g-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/cf80a1fa11c7/d4ra06121g-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/d56c5a8d80fd/d4ra06121g-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/566641afdfe6/d4ra06121g-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/9881c022a578/d4ra06121g-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/33f22f4e676a/d4ra06121g-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/cc696b336cd6/d4ra06121g-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/7025f395a82d/d4ra06121g-s2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/0381248abba6/d4ra06121g-s3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/44a919789f77/d4ra06121g-s4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/39f4d4a9134d/d4ra06121g-s5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/ab7bc088cb29/d4ra06121g-c1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/1ccd61560319/d4ra06121g-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/1e75ed21b69f/d4ra06121g-c2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/a92a3b61e0bf/d4ra06121g-c3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/5051a4848ebf/d4ra06121g-c4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/ac6d838cabaa/d4ra06121g-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/294b16497184/d4ra06121g-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/ada5f1ef4713/d4ra06121g-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/cf80a1fa11c7/d4ra06121g-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/d56c5a8d80fd/d4ra06121g-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/566641afdfe6/d4ra06121g-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b52/11487511/9881c022a578/d4ra06121g-f9.jpg

相似文献

1
New triazole-based hybrids as neurotropic agents.新型基于三唑的杂合物作为亲神经药物。
RSC Adv. 2024 Oct 18;14(45):32922-32943. doi: 10.1039/d4ra06121g. eCollection 2024 Oct 17.
2
Evaluation of Neurotropic Activity and Molecular Docking Study of New Derivatives of pyrano[4″,3″:4',5']pyrido[3',2':4,5]thieno[3,2-]pyrimidines on the Basis of pyrano[3,4-]pyridines.基于吡喃并[3,4-]吡啶的吡咯并[4″,3″:4',5']吡啶并[3',2':4,5]噻吩并[3,2-]嘧啶新衍生物的神经营养活性评价及分子对接研究。
Molecules. 2022 May 24;27(11):3380. doi: 10.3390/molecules27113380.
3
New Bicyclic Pyridine-Based Hybrids Linked to the 1,2,3-Triazole Unit: Synthesis via Click Reaction and Evaluation of Neurotropic Activity and Molecular Docking.新型双环吡啶基杂合体与 1,2,3-三唑单元相连:通过点击反应合成及神经毒性活性评价和分子对接。
Molecules. 2023 Jan 17;28(3):921. doi: 10.3390/molecules28030921.
4
Synthesis and Neurotropic Activity of New Heterocyclic Systems: Pyridofuro[3,2-]pyrrolo[1,2-]pyrimidines, Pyridofuro[3,2-]pyrido[1,2-]pyrimidines and Pyridofuro[3',2':4,5]pyrimido[1,2-]azepines.新型杂环体系:吡啶并[3,2-f]吡咯并[1,2-a]嘧啶、吡啶并[3,2-f]哒嗪并[1,2-a]嘧啶和吡啶并[3',2':4,5]嘧啶并[1,2-a]氮杂卓的合成及神经活性
Molecules. 2021 Jun 1;26(11):3320. doi: 10.3390/molecules26113320.
5
Derivatives of a new heterocyclic system - pyrano[3,4-][1,2,4]triazolo[4,3-]pyridines: synthesis, docking analysis and neurotropic activity.一种新的杂环体系——吡喃并[3,4-][1,2,4]三唑并[4,3-]吡啶的衍生物:合成、对接分析及神经趋向活性
Medchemcomm. 2019 Jun 19;10(8):1399-1411. doi: 10.1039/c9md00187e. eCollection 2019 Aug 1.
6
Design, synthesis, molecular docking and pharmacological evaluation of novel triazine-based triazole derivatives as potential anticonvulsant agents.新型三嗪基三唑衍生物的设计、合成、分子对接及作为潜在抗惊厥药物的药理学评价。
Bioorg Med Chem Lett. 2022 Dec 1;77:129042. doi: 10.1016/j.bmcl.2022.129042. Epub 2022 Nov 1.
7
Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro.用于预防小鼠中NMDLA诱导的癫痫发作/死亡、最大电休克和戊四氮癫痫发作以及体外拮抗MK801结合的化合物分类。
Arch Int Pharmacodyn Ther. 1992 May-Jun;317:16-34.
8
Design, Synthesis and Evaluation of the Antidepressant and Anticonvulsant Activities of Triazole-Containing Benzo[d]oxazoles.含三唑的苯并恶唑类化合物的抗抑郁和抗惊厥活性的设计、合成与评价。
CNS Neurol Disord Drug Targets. 2017;16(2):187-198. doi: 10.2174/1871527315666160822112501.
9
Pharmacological evaluation of novel 1-[4-(4-benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-phenyl]-3-phenyl-urea as potent anticonvulsant and antidepressant agent.新型1-[4-(4-苯并[1,3]二氧杂环戊烯-5-基甲基-哌嗪-1-基)-苯基]-3-苯基脲作为强效抗惊厥和抗抑郁剂的药理学评价
Pharmacol Rep. 2016 Apr;68(2):250-8. doi: 10.1016/j.pharep.2015.08.013. Epub 2015 Sep 10.
10
Evidence for the involvement of a GABAergic mechanism in the effectiveness of natural and synthetically modified incensole derivatives in neuropharmacological disorders: A computational and pharmacological approach.在神经药理学疾病中,涉及 GABA 能机制的证据表明天然和合成修饰的 incenseole 衍生物的有效性:一种计算和药理学方法。
Phytochemistry. 2019 Jul;163:58-74. doi: 10.1016/j.phytochem.2019.04.007. Epub 2019 Apr 20.

引用本文的文献

1
Design, Synthesis, and Pharmacological Activity of the -(4-(1H-1,2,4-Triazol-1-yl)phenyl)-substituted-amide Derivatives.-(4-(1H-1,2,4-三唑-1-基)苯基)取代酰胺衍生物的设计、合成及药理活性
Molecules. 2025 Aug 18;30(16):3400. doi: 10.3390/molecules30163400.
2
Synthesis and Neurotropic Activity of New 5-Piperazinopyrazolo[3,4-]-2,7-naphthyridines and Isoxazolo[5,4-]-2,7-naphthyridines.新型5-哌嗪基吡唑并[3,4 - ] - 2,7 - 萘啶和异恶唑并[5,4 - ] - 2,7 - 萘啶的合成及其神经活性
Pharmaceuticals (Basel). 2025 Apr 19;18(4):597. doi: 10.3390/ph18040597.
3
Synthesis, Crystal Structures, Hirshfeld Surface Analysis, Computational Investigations, Thermal Properties, and Electrochemical Analysis of Two New Cu(II) and Co(II) Coordination Polymers with the Ligand 5-Methyl-1-(pyridine-4-yl-methyl)-1H-1,2,3-triazole-4-carboxylate.

本文引用的文献

1
New Bicyclic Pyridine-Based Hybrids Linked to the 1,2,3-Triazole Unit: Synthesis via Click Reaction and Evaluation of Neurotropic Activity and Molecular Docking.新型双环吡啶基杂合体与 1,2,3-三唑单元相连:通过点击反应合成及神经毒性活性评价和分子对接。
Molecules. 2023 Jan 17;28(3):921. doi: 10.3390/molecules28030921.
2
Design, Synthesis, and Evaluation of Anticonvulsant Activities of New Triazolopyrimidine Derivatives.新型三唑并嘧啶衍生物的抗惊厥活性设计、合成与评价
Front Chem. 2022 Jun 23;10:925281. doi: 10.3389/fchem.2022.925281. eCollection 2022.
3
Design, synthesis and evaluation of amino-3,5-dicyanopyridines and thieno[2,3-b]pyridines as ligands of adenosine A receptors for the potential treatment of epilepsy.
两种新型含5-甲基-1-(吡啶-4-基甲基)-1H-1,2,3-三唑-4-羧酸酯配体的Cu(II)和Co(II)配位聚合物的合成、晶体结构、 Hirshfeld表面分析、计算研究、热性质及电化学分析
Int J Mol Sci. 2025 Feb 15;26(4):1671. doi: 10.3390/ijms26041671.
氨基-3,5-二氰基吡啶和噻吩并[2,3-b]吡啶作为腺苷A受体配体用于癫痫潜在治疗的设计、合成与评估
Med Chem Res. 2022;31(8):1277-1297. doi: 10.1007/s00044-022-02908-9. Epub 2022 May 24.
4
Recent Advances in Bioactive Flavonoid Hybrids Linked by 1,2,3-Triazole Ring Obtained by Click Chemistry.点击化学构建的 1,2,3-三氮唑键连接的生物活性黄酮杂合体的最新进展。
Molecules. 2021 Dec 30;27(1):230. doi: 10.3390/molecules27010230.
5
Synthesis of Biologically Relevant 1,2,3- and 1,3,4-Triazoles: From Classical Pathway to Green Chemistry.生物相关的 1,2,3-和 1,3,4-三唑的合成:从经典途径到绿色化学。
Molecules. 2021 Sep 18;26(18):5667. doi: 10.3390/molecules26185667.
6
Synthesis of 3,3-dimethyl-6-oxopyrano[3,4-c]pyridines and their antiplatelet and vasodilatory activity.3,3-二甲基-6-氧代吡喃并[3,4-c]吡啶的合成及其抗血小板和血管扩张活性。
J Pharm Pharmacol. 2022 Jun 9;74(6):887-895. doi: 10.1093/jpp/rgab075.
7
1,2,4-Triazoles as Important Antibacterial Agents.1,2,4-三唑类作为重要的抗菌剂。
Pharmaceuticals (Basel). 2021 Mar 7;14(3):224. doi: 10.3390/ph14030224.
8
Synthesis and antimicrobial activity of new 2-piperazin-1-yl-N-1,3-thiazol-2-ylacetamides of cyclopenta[c]pyridines and pyrano[3,4-c]pyridines.环戊并[c]吡啶和吡喃并[3,4-c]吡啶的新 2-哌嗪-1-基-N-1,3-噻唑-2-基乙酰胺的合成及抗菌活性。
Arch Pharm (Weinheim). 2021 Jan;354(1):e2000208. doi: 10.1002/ardp.202000208. Epub 2020 Oct 7.
9
New vinyl-1,2,4-triazole derivatives as antimicrobial agents: Synthesis, biological evaluation and molecular docking studies.新型乙烯基-1,2,4-三唑衍生物作为抗菌剂:合成、生物评价及分子对接研究。
Bioorg Med Chem Lett. 2020 Sep 1;30(17):127368. doi: 10.1016/j.bmcl.2020.127368. Epub 2020 Jun 26.
10
Synthesis and evaluation of anticonvulsant activities of 7-phenyl-4,5,6,7-tetrahydrothieno[3,2-b ]pyridine derivatives.7-苯基-4,5,6,7-四氢噻吩并[3,2-b]吡啶衍生物的合成与抗惊厥活性评价。
Arch Pharm (Weinheim). 2019 Oct;352(10):e1900106. doi: 10.1002/ardp.201900106. Epub 2019 Jul 31.